NCT00712933 - A Continuation Trial for Subjects With Lupus That Completed Protocol HGS1006-C1056 or HGS1006-C1057 | Biotech Hunter

Enrollment

738

Participants

Timeline

Start Date

May 30, 2008

Primary Completion Date

December 9, 2016

Study Completion Date

December 9, 2016

Conditions

Systemic Lupus Erythematosus

Interventions

DRUG

belimumab

"Recombinant, fully human, monoclonal antibody~Comparison of the 1 mg/kg and 10 mg/kg dose of belimumab given IV every 28 days."

Trial Locations (110)

100

GSK Investigational Site, Taipei

333

GSK Investigational Site, Gueishan Township,Taoyuan County

402

GSK Investigational Site, Taichung

404

GSK Investigational Site, Taichung

662

GSK Investigational Site, Dalin Township, Chiayi County

807

GSK Investigational Site, Kaohsiung City

813

GSK Investigational Site, Kaohsiung City

833

GSK Investigational Site, Kaohsiung City

970

GSK Investigational Site, Hualien City

1000

GSK Investigational Site, Manila

1008

GSK Investigational Site, Sampaloc Manila

1015

GSK Investigational Site, Ciudad Autonoma de Buenos Aires

1102

GSK Investigational Site, Quezon City

1740

GSK Investigational Site, Las Piñas

2000

GSK Investigational Site, Rosario

4000

GSK Investigational Site, Liège

6000

GSK Investigational Site, Cebu City

7760

GSK Investigational Site, México

8000

GSK Investigational Site, Davao City

10117

GSK Investigational Site, Berlin

14059

GSK Investigational Site, Berlin

24105

GSK Investigational Site, Kiel

28046

GSK Investigational Site, Madrid

30625

GSK Investigational Site, Hanover

31048

GSK Investigational Site, Haifa

31096

GSK Investigational Site, Haifa

34362

GSK Investigational Site, Haifa

40705

GSK Investigational Site, Taichung

44160

GSK Investigational Site, Guadalajara

44280

GSK Investigational Site, Guadalajara

49100

GSK Investigational Site, Petah Tikva

52621

GSK Investigational Site, Ramat Gan

55131

GSK Investigational Site, Mainz

60590

GSK Investigational Site, Frankfurt am Main

76100

GSK Investigational Site, Rehovot

78240

GSK Investigational Site, San Luis Potosí City

79106

GSK Investigational Site, Freiburg im Breisgau

84101

GSK Investigational Site, Beersheba

91054

GSK Investigational Site, Erlangen

92150

GSK Investigational Site, Suresnes

115522

GSK Investigational Site, Moscow

150003

GSK Investigational Site, Yaroslavl

150023

GSK Investigational Site, Yaroslavl

190068

GSK Investigational Site, Saint Petersburg

191015

GSK Investigational Site, Saint Petersburg

194291

GSK Investigational Site, Saint Petersburg

226003

GSK Investigational Site, Lucknow

400006

GSK Investigational Site, Cluj-Napoca

500003

GSK Investigational Site, Secunderabad

500482

GSK Investigational Site, Hyderabad, Andhra Pradesh

560034

GSK Investigational Site, Bangalore

695029

GSK Investigational Site, Trivandrum

2570017

GSK Investigational Site, Viña del Mar

8431657

GSK Investigational Site, Santiago

90610000

GSK Investigational Site, Porto Alegre

C1419AHN

GSK Investigational Site, Ciudad Autonoma de Buenos Aires

B1904CFH,

GSK Investigational Site, La Plata

T4000AXL

GSK Investigational Site, San Miguel de Tucumán

C1280AEB

GSK Investigational Site, Buenos Aires

C1417EYG

GSK Investigational Site, Buenos Aires

C1426AAL

GSK Investigational Site, Ciudad Autonoma Buenos Aires

A-1100

GSK Investigational Site, Vienna

40.150-410

GSK Investigational Site, Salvador

74110-120

GSK Investigational Site, Goiânia

36010-570

GSK Investigational Site, Juiz de Fora

50670-420

GSK Investigational Site, Recife

04039-901

GSK Investigational Site, São Paulo

13083-888

GSK Investigational Site, Campinas

22411-001

GSK Investigational Site, Rio de Janeiro

04032-060

GSK Investigational Site, São Paulo

04266-010

GSK Investigational Site, São Paulo

M5T 2S8

GSK Investigational Site, Toronto

H3G 1A4

GSK Investigational Site, Montreal

Unknown

GSK Investigational Site, Barranquilla

GSK Investigational Site, Bogotá

GSK Investigational Site, Bucaramanga

GSK Investigational Site, Medellín

GSK Investigational Site, Chai Wan

GSK Investigational Site, New Territories

GSK Investigational Site, Surco

GSK Investigational Site, Seoul

625 00

GSK Investigational Site, Brno - Bohunice

500 05

GSK Investigational Site, Hradec Králové

775 20

GSK Investigational Site, Olomouc

128 50

GSK Investigational Site, Prague

04103

GSK Investigational Site, Leipzig

07743

GSK Investigational Site, Jena

00152

GSK Investigational Site, Roma

6229 HX

GSK Investigational Site, Maastricht

3015 CE

GSK Investigational Site, Rotterdam

3083 AN

GSK Investigational Site, Rotterdam

Callao 2

GSK Investigational Site, Callao

Lima 27

GSK Investigational Site, Lima

26-200

GSK Investigational Site, Gmina Końskie

00716

GSK Investigational Site, Ponce

00936-5067

GSK Investigational Site, San Juan

020125

GSK Investigational Site, Bucharest

020475

GSK Investigational Site, Bucharest

021392

GSK Investigational Site, Bucharest

921 12

GSK Investigational Site, Piešťany

602-715

GSK Investigational Site, Busan

302-799

GSK Investigational Site, Daejeon

400-711

GSK Investigational Site, Incheon

602-739

GSK Investigational Site, Pusan

137-701

GSK Investigational Site, Seoul

443-721

GSK Investigational Site, Suwon, Kyonggi-do

08036

GSK Investigational Site, Barcelona

SE-171 76

GSK Investigational Site, Stockholm

SE1 7EH

GSK Investigational Site, London

NE7 7DN

GSK Investigational Site, Newcastle upon Tyne